A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
for Transfusion-dependent Alpha-Thalassemia
Drug: Mitapivat
Sites in Philadelphia +2 more locations
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All·Age: 1 - 17
Code: NCT07506863·Phase 3·Recruiting·Listed Apr 2026